Astrid W. Oosten - Concepedia

Author

Astrid W. Oosten

Erasmus MC Cancer Institute ORCID

Also Known As

A W Oosten, A. Oosten, A. W. Oosten, A.W. Oosten, Astrid Oosten, Astrid W Oosten, Astrid W. Oosten

Publications

372

Citations

H-Index

Concepts

All Affiliations

Erasmus MC Cancer Institute Erasmus MC Radboud University Medical Center Netherlands Comprehensive Cancer Organisation Radboud University Nijmegen

About

Astrid W. Oosten is an author at Erasmus MC Cancer Institute specializing in medicine, cancer research, and surgical oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	2	2	64
2	Health Sciences	1	1	20
3	Anesthesia	1	1	20
4	Obstetrics	1	1	44
5	Pathology	1	1	44

Astrid W. Oosten

Publications

211

Citations

H-Index

Page 1

	Year	Citations
Outcomes of First-Line Chemotherapy in Patients with Advanced or Metastatic Leiomyosarcoma of Uterine and Non-Uterine Origin Astrid W. Oosten, C. Seynaeve, P.I.M. Schmitz, Sarcoma Surgical OncologyCancer ManagementGynecologyPathologyMetastatic Lms	2009	44
Treatment with subcutaneous and transdermal fentanyl: results from a population pharmacokinetic study in cancer patients Astrid W. Oosten, João A. Abrantes, Siv Jönsson, European Journal of Clinical Pharmacology	2016	28
A Prospective Population Pharmacokinetic Study on Morphine Metabolism in Cancer Patients Astrid W. Oosten, João A. Abrantes, Siv Jönsson, Clinical Pharmacokinetics	2016	21
Higher doses of opioids in patients who need palliative sedation prior to death: Cause or consequence? Astrid W. Oosten, Wendy H. Oldenmenger, C. van Zuylen, European Journal of Cancer Palliative CareHigher DosesOpioid EpidemicHealth SciencesPain Medicine	2011	20
Opioid Treatment Failure in Cancer Patients: The Role of Clinical and Genetic Factors Astrid W. Oosten, Maja Matić, Ron HN van Schaik, Pharmacogenomics	2016	18
Improved Efficacy of First-Line Imatinib in Advanced Gastrointestinal Stromal Tumors (GIST): The Dutch GIST Registry Data Mahmoud Mohammadi, Nikki S. IJzerman, Dide den Hollander, Targeted Oncology	2023	15
Prospective Analysis in GIST Patients on the Role of Alpha-1 Acid Glycoprotein in Imatinib Exposure Sander Bins, Karel Eechoute, Jacqueline S. L. Kloth, Clinical Pharmacokinetics	2016	14
Clinicopathological features and treatment outcome of oesophageal gastrointestinal stromal tumour (GIST): A large, retrospective multicenter European study Mahmoud Mohammadi, Nikki S. IJzerman, Peter Hohenberger, European Journal of Surgical Oncology	2021	14
Priorities and preferences of advanced soft tissue sarcoma patients starting palliative chemotherapy: baseline results from the HOLISTIC study Eugenie Younger, Robin L. Jones, Dide den Hollander, ESMO Open	2021	14
Minimal Increase in Survival Throughout the Years in Patients with Soft Tissue Sarcoma with Synchronous Metastases: Results of a Population-Based Study Melissa Vos, Vincent K.Y. Ho, Astrid W. Oosten, The Oncologist	2018	13

Page 1